Medicare Enrolled
Dr. Alaa Owainati, MD
Hematology & Oncology · Pontiac, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Owainati from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Owainati?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Owainati
Dr. Alaa Owainati is a hematology & oncology specialist in Pontiac, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Owainati performed 1,170 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Owainati received a total of $7,467 from 52 pharmaceutical and/or device companies across 349 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Owainati is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 37% volume in MI
$7,467 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,170
Medicare services
Top 37% in MI for hematology & oncology
Not available
Unique patients (not deduplicated)
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
294 | $63 | $109 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
213 | $66 | $108 |
| Chronic care management, first 30 minutes This service covers the initial 30 minutes of care coordination for patients with two or more chronic conditions. It is provided personally by a healthcare professional each calendar month. |
118 | $68 | $162 |
| Chronic care management, additional 30 minutes This service covers an extra 30 minutes of care management provided by a healthcare professional for patients with two or more chronic conditions. It is billed per calendar month in addition to the standard chronic care management time. |
101 | $48 | $118 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
100 | $98 | $156 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
81 | $136 | $275 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
61 | $39 | $63 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
56 | $95 | $165 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
52 | $141 | $228 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
40 | $98 | $206 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
37 | $50 | $111 |
| New patient office visit, complex (60-74 min) | 17 | $176 | $291 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,467
Total received (2018-2024)
Avg $1,067/year across 7 years
Top 23% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
349
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$692
2023
$1,671
2022
$896
2021
$782
2020
$1,541
2019
$909
2018
$975
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$241
Eisai Inc.
$64
Coherus Biosciences Inc.
$56
E.R. Squibb & Sons, L.L.C.
$44
Merck Sharp & Dohme LLC
$43
PFIZER INC.
$42
Daiichi Sankyo Inc.
$41
PharmaEssentia USA Corporation
$27
Lilly USA, LLC
$24
Novartis Pharmaceuticals Corporation
$22
TerSera Therapeutics LLC
$20
Ipsen Biopharmaceuticals, Inc
$19
Janssen Biotech, Inc.
$18
Aveo Pharmaceuticals, Inc.
$16
ARRAY BIOPHARMA INC
$13
Top 3 companies account for 52.2% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$955
Coherus Biosciences Inc.
$810
AstraZeneca Pharmaceuticals LP
$642
E.R. Squibb & Sons, L.L.C.
$604
Amgen Inc.
$466
PFIZER INC.
$377
Janssen Biotech, Inc.
$371
Lilly USA, LLC
$322
Celgene Corporation
$321
Genentech USA, Inc.
$172
Boehringer Ingelheim Pharmaceuticals, Inc.
$154
Merck Sharp & Dohme LLC
$141
Astellas Pharma US Inc
$133
Eisai Inc.
$130
Daiichi Sankyo Inc.
$125
GENZYME CORPORATION
$121
Spectrum Pharmaceuticals Inc.
$118
Takeda Pharmaceuticals U.S.A., Inc.
$117
Novartis Pharmaceuticals Corporation
$111
Incyte Corporation
$102
Merck Sharp & Dohme Corporation
$100
GlaxoSmithKline, LLC.
$98
Gilead Sciences, Inc.
$78
TerSera Therapeutics LLC
$64
AVEO Pharmaceuticals, Inc.
$59
Dova Pharmaceuticals
$57
ARRAY BIOPHARMA INC
$55
Inari Medical, Inc.
$53
Seagen Inc.
$48
INSYS Therapeutics Inc
$45
Taiho Oncology, Inc.
$41
Alexion Pharmaceuticals, Inc.
$37
EMD Serono, Inc.
$37
Mylan Institutional Inc.
$33
Teva Pharmaceuticals USA, Inc.
$30
ABBVIE INC.
$30
Aveo Pharmaceuticals, Inc.
$29
PharmaEssentia USA Corporation
$27
Acrotech Biopharma LLC
$26
Deciphera Pharmaceuticals Inc.
$21
G1 Therapeutics, Inc.
$20
Janssen Pharmaceuticals, Inc
$20
Ipsen Biopharmaceuticals, Inc
$19
Pharmacosmos Therapeutics Inc.
$19
Adaptive Biotechnologies Corporation
$19
Seattle Genetics, Inc.
$19
Kite Pharma, Inc.
$18
Puma Biotechnology, Inc.
$16
Mylan Pharmaceuticals Inc.
$16
Apellis Pharmaceuticals, Inc.
$16
Clovis Oncology, Inc.
$15
Acerta Pharma LLC
$13
Top 3 companies account for 32.2% of all-time payments
Associated products mentioned in payments ›
AFINITOR · ALIMTA · ANDEXXA · Abraxane · BENDEKA · BESREMI · BLENREP · BRAFTOVI · Bavencio · CABLIVI · CALQUENCE · CHANTIX · COSELA · CYRAMZA · DARZALEX · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ERBITUX · EXKIVITY · Empaveli · Enhertu · FASENRA · FLOWTRIEVER CATHETER · FOTIVDA · Folotyn · Fulphila · GAZYVA · GILOTRIF · HEMADY · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONOFERRIC · MVASI · NINLARO · Nerlynx · Neulasta · Nplate · OPDIVO · Onivyde · PADCEV · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rubraca · S · SARCLISA · SHINGRIX · SOLIRIS · SPRYCEL · SYNDROS · Stivarga · TAGRISSO · TECENTRIQ · TECVAYLI · TEPMETKO · Trodelvy · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · Vectibix · Venclexta · XALKORI · XARELTO · XGEVA · XTANDI · Xofigo · ZEJULA · ZOLADEX · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
121
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
TRINITY HEALTH OAKLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Owainati is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Owainati experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Owainati performed 294 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Owainati receive payments from pharmaceutical companies?
Yes. Dr. Owainati received a total of $7,467 from 52 companies across 349 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Owainati's costs compare to other hematology & oncology specialists in Pontiac?
Dr. Owainati's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Owainati) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Pontiac
Browse hematology & oncology specialists in Pontiac ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Coherus Biosciences Inc. Payments to Doctors
See all physicians who received payments from Coherus Biosciences Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology